BC
CC icon

Bridgefront Capital’s Chemours CC Stock Holding History

Bridgefront Capital’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-59,715
Closed -$946K – 555
2025
Q3 		$946K Sell
59,715
-12,839
-18% -$186K 0.28% 103
2025
Q2 		$831K Buy
+72,554
New +$818K 0.22% 144
2025
Q1 		– Sell
-38,370
Closed -$648K – 643
2024
Q4 		$648K Buy
+38,370
New +$746K 0.22% 145
2024
Q3 		– Sell
-19,750
Closed -$446K – 547
2024
Q2 		$446K Buy
+19,750
New +$517K 0.19% 185

Other funds holding CC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bridgefront Capital's CC Position: Q4 2025 in Review

Bridgefront Capital sold out of Chemours (CC) in Q4 2025, closing a stake of 59,715 shares — an estimated $946K sold.

Bridgefront Capital first reported a position in CC in Q2 2024 and held it in 4 quarters. The position peaked at $946K in Q3 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Bridgefront Capital reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 59,715 Chemours shares in Q4 2025, an estimated $946K.
  • Bridgefront Capital first reported a position in Chemours in Q2 2024 and held it in 4 quarters.
  • Bridgefront Capital's Chemours position peaked at $946K in Q3 2025.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.